Dr. Edward Abadir, MD
Claim this profileRoyal Prince Alfred Hospital
Studies Relapse
Studies Acute Myelogenous Leukemia
1 reported clinical trial
1 drug studied
More about Edward Abadir, MD
Clinical Trial Related2 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Edward Abadir, MD has experience with
- WU-NK-101
Breakdown of trials Edward Abadir, MD has run
Acute Myelogenous Leukemia
Acute Myeloid Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Edward Abadir, MD specialize in?
Edward Abadir, MD focuses on Relapse and Acute Myelogenous Leukemia. In particular, much of their work with Relapse has involved Stage IV patients, or patients who are undergoing treatment.
Is Edward Abadir, MD currently recruiting for clinical trials?
No, Edward Abadir, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Edward Abadir, MD has studied deeply?
Yes, Edward Abadir, MD has studied treatments such as WU-NK-101.
What is the best way to schedule an appointment with Edward Abadir, MD?
Apply for one of the trials that Edward Abadir, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.